Adimmune Corporation (TPE: 4142)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
26.95
-0.45 (-1.64%)
Sep 11, 2024, 1:30 PM CST
-18.33%
Market Cap 11.30B
Revenue (ttm) 1.66B
Net Income (ttm) -607.92M
Shares Out 421.51M
EPS (ttm) -1.45
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 752,131
Open 26.80
Previous Close 27.40
Day's Range 26.80 - 27.20
52-Week Range 24.35 - 36.60
Beta 0.46
Analysts n/a
Price Target n/a
Earnings Date Nov 11, 2024

About Adimmune

Adimmune Corporation manufactures and sells human vaccines in Taiwan. It offers AdimFlu-S, a quadrivalent influenza vaccine; tetanus toxoid alum precipitated product that is used for the prevention of tetanus after injury; Japanese encephalitis vaccines; Trivalent influenza vaccines; Quadrivalent influenza vaccine; Influenza A (H1N1) Virus Monovalent Vaccine; Tetanus Toxoid; and purified Tuberculin, as well as contract manufacturing services. The company was formerly known as Kuo Kwang Serum and Vaccine Manufacture Co., Ltd. and changed its nam... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1965
Employees 564
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 4142
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.